These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4671038)

  • 1. Immunotherapy in bronchogenic carcinoma.
    Takita H; Brugarolas A
    Surg Forum; 1972; 23(0):98-9. PubMed ID: 4671038
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant immunotherapy for bronchogenic carcinoma: preliminary results.
    Takita H; Brugarolas A
    Cancer Chemother Rep 3; 1973 Mar; 4(2):293-8. PubMed ID: 4729333
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-specific immunostimulation in bronchogenic cancer.
    Israel L
    Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
    [No Abstract]   [Full Text] [Related]  

  • 4. [The immunostate and immunotherapy of primary bronchogenic carcinoma (author's transl)].
    Deng WW
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(1):56-8. PubMed ID: 551912
    [No Abstract]   [Full Text] [Related]  

  • 5. Small-cell bronchogenic carcinoma; advances in treatment.
    Bergevin PR
    N Y State J Med; 1980 Nov; 80(12):1847-50. PubMed ID: 6262689
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic status before and during immunotherapy (immuneprofile).
    Alth G; Denck H; Fischer M; Karrer K; Kokron O; Korizek E; Micksche M; Ogris E; Reider C; Titscher R; Wrba H
    Cancer Chemother Rep 3; 1973 Mar; 4(2):275-7. PubMed ID: 4729329
    [No Abstract]   [Full Text] [Related]  

  • 7. Selecting appropriate therapy for bronchial carcinoma.
    Shields TW
    Geriatrics; 1974 Jul; 29(7):54-60. PubMed ID: 4835739
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspects of the immunologic treatment of lung cancer.
    Alth G; Denck H; Fischer M; Karrer K; Kokron O; Korizek E; Micksche M; Ogris E; Reider C; Titscher R; Wrba H
    Cancer Chemother Rep 3; 1973 Mar; 4(2):271-4. PubMed ID: 4729328
    [No Abstract]   [Full Text] [Related]  

  • 9. The problem of oat-cell carcinoma.
    Scannell JG
    N Engl J Med; 1970 Jan; 282(2):98-9. PubMed ID: 5409501
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy of bronchial carcinoma (author's transl)].
    Undurraga A
    Rev Med Chil; 1981 Sep; 109(9):887-93. PubMed ID: 7342265
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future.
    Dana M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):153-5. PubMed ID: 4734076
    [No Abstract]   [Full Text] [Related]  

  • 12. Intralesional injection of BCG using the fibreoptic bronchoscope in the treatment of bronchogenic carcinoma.
    Millar JW; Hunter AM; Wightman AJ; Horne NW
    Eur J Respir Dis; 1980 Jun; 61(3):162-6. PubMed ID: 7439279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bronchial cancer. The therapeutic stage].
    Dournovo P
    Soins; 1994 Dec-1995 Jan; (591-592):18-22. PubMed ID: 7652599
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stimulating immunity with the use of Corynebacterium parvum after resection of carcinoma of bronchial origin. Clinical aspects].
    Dangubić V; Dujić A; Lilić D; Kolasinović N; Jeremić K
    Srp Arh Celok Lek; 1982 Sep; 110(9):1017-24. PubMed ID: 7182936
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostic strategies in bronchial carcinoma].
    Feddersen CO; von Wichert P
    Internist (Berl); 1994 Aug; 35(8):724-9. PubMed ID: 7960552
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant immunotherapy in bronchogenic carcinoma.
    Takita H; Minowada J; Han T; Takada M; Lane WW
    Ann N Y Acad Sci; 1976; 277(00):345-54. PubMed ID: 1069554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for immunotherapy in small cell bronchogenic carcinoma?
    Israel L
    Recent Results Cancer Res; 1985; 97():157-61. PubMed ID: 2986242
    [No Abstract]   [Full Text] [Related]  

  • 18. Appraisal of choice and results of treatment for bronchogenic carcinoma.
    Carlens E
    Chest; 1974 Apr; 65(4):442-5. PubMed ID: 4819249
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
    Host H
    Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical management of bronchogenic carcinoma.
    Baker RR
    Johns Hopkins Med J; 1967 Dec; 121(6):401-11. PubMed ID: 6062094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.